Exploring the riskreward balance in focal therapy for prostate cancera contribution to the debate

Exploring the risk-reward balance in focal therapy for prostate cancer—a contribution to the debate

01:36 EST 22 Jan 2019 | NEJM

More From BioPortfolio on "Exploring the risk-reward balance in focal therapy for prostate cancer—a contribution to the debate"